MDSCs have been shown to promote tumor angiogenesis via secretion of VEGF as well as MMP-9, and also augment the expression of checkpoint receptor ligand PD-L1 (Mirghorbani et al., 2013). This evidence concerns the gene VEGFA and neoplasm.